Vincent Hennemand, MSc, MBA
Mr. Hennemand is a core member of Sonde Health and Vice President of Company Development and Operations at PureTech. He was previously a Principal in Sanofi’s corporate R&D venture group (“Sunrise”) where he was responsible for developing and managing new investment opportunities including Myokardia, Voyager Therapeutics, WarpDrive Bio and Portal Instruments. Prior, Mr. Hennemand was the Chief of Staff to the President of Global R&D and the General Secretary for the Corporate Scientific Advisory Committee (SDSAC), which investigates scientific proposals and projects of potential interest to Sanofi. He has a Msc in Engineering from Ecole Normal Superieure Arts et Metiers in France and an MBA (2015) from MIT where he received a Martin Trust Center scholarship as Healthcare Sector Practice Leader for the Institute.